|
Volumn 447, Issue 1, 2002, Pages 109-114
|
Carmoxirole is able to reduce amisulpride-induced hyperprolactinemia without affecting its central effect
|
Author keywords
Antipsychotic; Benzamide; Depression; Prolactin
|
Indexed keywords
BROMOCRIPTINE;
CARMOXIROLE;
DOPAMINE 2 RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
DRUG DERIVATIVE;
INDOLE DERIVATIVE;
NEUROLEPTIC AGENT;
PROLACTIN;
PYRIDINE DERIVATIVE;
SULPIRIDE;
SULTOPRIDE;
AMISULPRIDE;
APOMORPHINE;
ANIMAL;
ARTICLE;
BINDING COMPETITION;
BLOOD;
CHEMICALLY INDUCED DISORDER;
DRUG EFFECT;
HYPERPROLACTINEMIA;
HYPOPHYSIS;
IN VITRO STUDY;
MALE;
METABOLISM;
RAT;
SPRAGUE DAWLEY RAT;
SYNAPTOSOME;
ULTRASTRUCTURE;
YAWNING;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
BLOOD BRAIN BARRIER;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG TRANSPORT;
NONHUMAN;
PRIORITY JOURNAL;
PROLACTIN BLOOD LEVEL;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
BINDING, COMPETITIVE;
BROMOCRIPTINE;
DOPAMINE AGONISTS;
HYPERPROLACTINEMIA;
INDOLES;
MALE;
PITUITARY GLAND;
PROLACTIN;
PYRIDINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RECEPTORS, DOPAMINE D2;
SULPIRIDE;
SYNAPTOSOMES;
YAWNING;
ANIMAL;
IN VITRO;
SUPPORT, NON-U.S. GOV'T;
|
EID: 0037188757
PISSN: 00142999
EISSN: None
Source Type: Journal
DOI: 10.1016/S0014-2999(02)01896-4 Document Type: Article |
Times cited : (11)
|
References (32)
|